We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+17.12%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.13B
AUM Growth
+$460M
Cap. Flow
+$219M
Cap. Flow %
10.3%
Top 10 Hldgs %
40.03%
Holding
90
New
27
Increased
17
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$32.8M
2
ZBH icon
Zimmer Biomet
ZBH
+$23.4M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$19.8M
4
DXCM icon
DexCom
DXCM
+$19.6M
5
WST icon
West Pharmaceutical
WST
+$18.9M

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$41.2M
2
INBX
Inhibrx, Inc. Common Stock
INBX
+$17.9M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$14.2M
4
ROIV icon
Roivant Sciences
ROIV
+$13.6M
5
SANA icon
Sana Biotechnology
SANA
+$9.05M

Sector Composition

Rank Sector Weight
1 Healthcare 90.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELC icon
51
Celcuity
CELC
$4.55B
$10.7M 0.5%
497,002
+340,005
+217% +$5.43M
UNH icon
52
UnitedHealth
UNH
$367B
$9.58M 0.45%
19,361
– –
CMPS
53
Compass Pathways
CMPS
$1.83B
$9.07M 0.43%
1,089,592
+750,831
+222% +$7.57M
MDGL icon
54
Madrigal Pharmaceuticals
MDGL
$11.8B
$8M 0.38%
+29,973
New +$7.06M
ALGN icon
55
Align Technology
ALGN
$12.1B
$7.46M 0.35%
+22,751
New +$6.67M
INSP icon
56
Inspire Medical Systems
INSP
$1.7B
$7.21M 0.34%
+33,557
New +$6.58M
ITCI
57
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.84M 0.32%
+98,879
New +$6.8M
SANA icon
58
Sana Biotechnology
SANA
$949M
$6.75M 0.32%
675,000
-1,208,337
-64% -$9.05M
GBIO
59
DELISTED
Generation Bio
GBIO
$6.6M 0.31%
162,249
– –
XENE icon
60
Xenon Pharmaceuticals
XENE
$6.24B
$6.48M 0.3%
150,554
-42,302
-22% -$1.95M
SILK
61
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$6.07M 0.29%
+331,064
New +$5.25M
DAWN
62
DELISTED
Day One Biopharmaceuticals
DAWN
$5.87M 0.28%
355,251
-948,324
-73% -$14.2M
ERAS icon
63
Erasca
ERAS
$6.34B
$5.22M 0.25%
2,535,102
-40,409
-2% -$80.8K
APLS
64
DELISTED
Apellis Pharmaceuticals
APLS
$4.88M 0.23%
+82,952
New +$5.29M
IOVA icon
65
Iovance Biotherapeutics
IOVA
$2.77B
$4.61M 0.22%
+310,754
New +$3.62M
ATXS
66
DELISTED
Astria Therapeutics
ATXS
$4.6M 0.22%
+327,045
New +$4.07M
CGEM icon
67
Cullinan Oncology
CGEM
$1.1B
$4.36M 0.21%
+255,967
New +$3.96M
SGMT icon
68
Sagimet Biosciences
SGMT
$540M
$4.35M 0.2%
802,712
+126,259
+19% +$907K
IOBT
69
DELISTED
IO Biotech
IOBT
$4.05M 0.19%
2,341,107
– –
CNTA
70
DELISTED
Centessa Pharmaceuticals
CNTA
$3.56M 0.17%
+314,674
New +$2.98M
EYPT icon
71
EyePoint Inc
EYPT
$1.08B
$3.53M 0.17%
170,871
– –
FXI icon
72
iShares China Large-Cap ETF
FXI
$4.29B
$3.4M 0.16%
+141,122
New +$3.25M
VKTX icon
73
Viking Therapeutics
VKTX
$3.88B
$2.69M 0.13%
+32,827
New +$1.46M
BLUE
74
DELISTED
bluebird bio
BLUE
$2.61M 0.12%
102,133
– –
OM icon
75
Outset Medical
OM
$96.4M
$2.59M 0.12%
77,869
+11,252
+17% +$570K
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q1 2024 Portfolio in Review

As of Q1 2024, PFM Health Sciences held 90 positions worth $2.13B, up 28% from $1.67B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PFM Health Sciences deployed $219M of net new capital in Q1 2024, opening 27 new positions and adding to 17 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 99,115 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 97% a quarter earlier.

On the sell side, the largest reduction was Inhibrx, Inc. Common Stock, an estimated $17.9M trimmed.

  • PFM Health Sciences's largest Q1 2024 buy was iShares Russell 2000 ETF: 99,115 shares worth $20.8M.
  • PFM Health Sciences added most to Intuitive Surgical in Q1 2024, an estimated $32.8M increase.
  • PFM Health Sciences's biggest Q1 2024 reduction was Inhibrx, Inc. Common Stock, cutting an estimated $17.9M.
  • PFM Health Sciences fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $41.2M.
  • PFM Health Sciences's ten largest holdings make up 40% of its $2.13B portfolio in Q1 2024.
  • PFM Health Sciences opened 27 new positions and closed 3 in Q1 2024.
  • PFM Health Sciences's portfolio value rose 28% quarter-over-quarter to $2.13B.

Based on PFM Health Sciences's 13F filing for Q1 2024, filed 14 May 2024.